Sascha P Fedyszyn - Net Worth and Insider Trading

Sascha P Fedyszyn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sascha P Fedyszyn owns 1 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) .

Click here to see the complete history of Sascha P Fedyszyn’s form 4 insider trades.

Insider Ownership Summary of Sascha P Fedyszyn

Ticker Comapny Transaction Date Type of Owner
ELOX Eloxx Pharmaceuticals Inc 2003-06-19 VP of Corp Dev &

Sascha P Fedyszyn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sascha P Fedyszyn Ownership Network

Ownership Network List of Sascha P Fedyszyn

No Data

Ownership Network Relation of Sascha P Fedyszyn

Insider Network Chart

Sascha P Fedyszyn Owned Company Details

What does Eloxx Pharmaceuticals Inc do?

Who are the key executives at Eloxx Pharmaceuticals Inc?

Sascha P Fedyszyn is the VP of Corp Dev & of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include director & PRESIDENT AND CEO Sumit Aggarwal , HEAD OF R&D Vijay Modur , and Chief Financial Officer Daniel E. Geffken .

Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eloxx Pharmaceuticals Inc Insider Transactions

No Available Data

Sascha P Fedyszyn Mailing Address

Above is the net worth, insider trading, and ownership report for Sascha P Fedyszyn. You might contact Sascha P Fedyszyn via mailing address: C/o Senesco Technologies Inc, New Brunswick Nj 08901.

Discussions on Sascha P Fedyszyn

No discussions yet.